Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,897Revenue $M75.4Net Margin (%)-69.0Z-Score15.4
Enterprise Value $M1,836EPS $-0.5Operating Margin %-65.6F-Score5
P/E(ttm))0Cash Flow Per Share $-0.5Pre-tax Margin (%)-69.0Higher ROA y-yN
Price/Book26.410-y EBITDA Growth Rate %-13.1Quick Ratio3.0Cash flow > EarningsY
Price/Sales16.65-y EBITDA Growth Rate %16.4Current Ratio3.1Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-86.7Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-249.1Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M160ROI % (ttm)-84.5Gross Margin Increase y-yY

Gurus Latest Trades with AVNR

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

AVNR is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


AVNR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
OCAMPO CHRISTINEVice President, Finance 2014-09-15Sell55,000$9.4517.46 view
PALEKAR ROHANSVP & Chief Commercial Officer 2014-09-15Sell25,000$11.5-3.48 view
OCAMPO CHRISTINEVice President, Finance 2014-08-26Sell2,110$6.181.97 view
Katkin KeithPresident and CEO 2014-08-01Sell9,670$5.26111.03 view
Siffert Joao MDSVP, R&D 2014-05-28Sell13,547$5.18114.29 view
Katkin KeithPresident and CEO 2014-05-28Sell442,212$5.01121.56 view
OCAMPO CHRISTINEVice President, Finance 2014-05-16Sell37,496$5.05119.8 view
Siffert Joao MDSVP, R&D 2013-12-18Sell5,970$2.63322.05 view
OCAMPO CHRISTINEVice President, Finance 2013-12-18Sell2,450$2.63322.05 view
Katkin KeithPresident and CEO 2013-12-18Sell29,515$2.67315.73 view

Press Releases about AVNR :

    Quarterly/Annual Reports about AVNR:

    News about AVNR:

    Articles On GuruFocus.com
    Weekly CEO Sells Highlight: Danaher Corporation, Orbitz Worldwide Inc., 3D Systems Corporation and A May 20 2013 
    Weekly CEO Sells Highlight: Universal Insurance Holdings Inc, Avanir Pharmaceuticals Inc, Bel Fuse I Jun 30 2012 
    Options V: Short-Term Strategy – Earning Money on Volatility Oct 19 2011 
    Avanir Pharmaceuticals Reports Operating Results (10-Q) Feb 07 2011 
    Avanir Pharmaceuticals Reports Operating Results (10-K) Dec 08 2010 
    Avanir Pharmaceuticals (AVNR) President and CEO Keith Katkin sells 195,300 Shares Dec 03 2010 
    Weekly CEO Sells Highlights: MAC, GNET, ASIA, and AVNR Sep 05 2010 
    Avanir Pharmaceuticals (AVNR) President and CEO Keith Katkin sells 102,874 Shares Sep 02 2010 
    Avanir Pharmaceuticals Reports Operating Results (10-Q) Aug 05 2010 
    Avanir Pharmaceuticals (AVNR) President and CEO Keith Katkin sells 105,906 Shares May 04 2010 


    More From Other Websites
    Most active Nasdaq-traded stocks Sep 19 2014
    Weakness Seen in Avanir Pharmaceuticals (AVNR): Stock Falls 6.5% Sep 19 2014
    4 stocks to watch Sep 18 2014
    Insider Trading Alert - RSG, HAL And AVNR Traded By Insiders Sep 18 2014
    Glimcher and Apple are big market movers Sep 16 2014
    Avanir Pharmaceuticals Shoots Up on Positive AVP-923 Data Sep 16 2014
    Is Avanir Pharma Fully Valued After Monday’s Rally? Sep 16 2014
    How to Trade the Market's Most-Active Stocks: RATE, AVNR, NPSP, TAP Sep 16 2014
    The Zacks Analyst Blog Highlights: Merck KGaA, Lannett, Avanir Pharmaceuticals, Anacor... Sep 16 2014
    Avanir Pharmaceuticals Sep 15 2014
    Technology Stocks Down As Rest Of The Market Starts Week Flat Sep 15 2014
    [video] U.S. Stocks Close Mixed with Nasdaq Slammed by Sell-off Sep 15 2014
    US STOCKS-Nasdaq slumps to worst day since July; S&P 500 dips Sep 15 2014
    US STOCKS-Nasdaq slumps to worst day since July; S&P 500 dips Sep 15 2014
    Taking Stock: Winners and Losers, Stock of the Day Sep 15 2014
    Terex Falls After Lowered Earnings Forecast; Avanir Pharmaceuticals Shares Surge Sep 15 2014
    US STOCKS-Tech shares drag Nasdaq, S&P 500 little changed Sep 15 2014
    US STOCKS-Tech shares drag Nasdaq, S&P 500 little changed Sep 15 2014
    Avanir Pharma soars on agitation drug study Sep 15 2014
    Avanir Pharma soars on agitation drug study Sep 15 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK